Orchestra BioMed is set to join the broad-market Russell 3000 Index, the small-cap Russell 2000 Index, and the Russell Microcap index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens today, June 26, 2023, according to a preliminary list of additions posted May 19, 2023.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on OBIO:
- Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
- Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer
- Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update